Tapio Visakorpi (T Visakorpi)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Transcription Factor

Radical Prostatectomy

Lower Urinary Tract Symptoms

Long Noncoding Rna

Top Venues

Cancer gene therapy

Endocrine-related cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Annika Kohvakka, Mina Sattari, Janika Nättinen, Ulla Aapola, Pavlína Gregorová, Teuvo L J Tammela, Hannu Uusitalo, L Peter Sarin, Tapio Visakorpi, Leena Latonen
Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer. Cancer gene therapy (2024)
Konsta Kukkonen, Bryn Autio-Kimura, Hanna Rauhala, Juha Kesseli, Matti Nykter, Leena Latonen, Tapio Visakorpi
Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen. Endocrine-related cancer 29 (12) (2022)
Sini K Eerola, Annika Kohvakka, Teuvo L J Tammela, Päivi J Koskinen, Leena Latonen, Tapio Visakorpi
Expression and ERG regulation of PIM kinases in prostate cancer. Cancer medicine 10 (10) (2021)
Dan J Woodcock, E Riabchenko, S Taavitsainen, Matti Kankainen, Gunes Gundem, Daniel S Brewer, P Ellonen, M Lepistö, Y A Golubeva, Andrew C Warner, T Tolonen, J Jasu, W B Isaacs, M R Emmert-Buck, M Nykter, Tapio Visakorpi, G Steven Bova, David C Wedge
Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy. Nature communications 11 (1) (2020)
Annika Kohvakka, Mina Sattari, Anastasia Shcherban, Matti Annala, Alfonso Urbanucci, Juha Kesseli, Teuvo L J Tammela, Kati Kivinummi, Leena Latonen, Matti Nykter, Tapio Visakorpi
AR and ERG drive the expression of prostate cancer specific long noncoding RNAs. Oncogene 39 (30) (2020)